Tiger Buford – retained recruiter dissecting orthopedics 
Sharing a quick example from S. Korea that has a small US office in Irvine.
CG MedTech is a South Korean orthopedic startup based in Uijeongbu, Gyeonggi Province, focused on developing and manufacturing orthopedic implants and medical devices. The company is a subsidiary of CGBio, a regenerative medicine specialist, and has recently undergone a leadership transition with the appointment of Yu Hyun-seung as its new CEO. Yu, who also serves as the CEO of CGBio, brings extensive experience in biomaterials and regenerative medicine, having founded Bioalpha (CGBio’s predecessor) in 2000 and developed notable products like NOVOSIS, Korea’s first bone morphogenetic protein (BMP-2)-based bone substitute system for orthopedics, and Facetem, a calcium filler for wrinkle improvement.
CG MedTech’s core business includes its Resomet orthopedic implant line, which utilizes biodegradable magnesium alloy, a material that aligns with the growing trend of bioresorbable implants in orthopedics. The company aims to expand its portfolio by leveraging CGBio’s expertise in biomaterial technology, global distribution networks, and marketing capabilities. This strategic alliance is intended to position CG MedTech as an integrated solution provider in spine and orthopedic surgery, combining regenerative medicine-based biomaterials with traditional metal implants. Their focus includes developing advanced convergence medical devices, enhancing joint marketing and sales networks globally, and integrating global licensing and clinical strategies.
Financially, CG MedTech reported 22.6 billion won ($15.3 million) in revenue for 2024, with an operating profit of 2.28 billion won, reflecting a 25% increase in profitability despite flat revenue growth. The company has a strong international presence, with overseas sales making up 58% of its total revenue (13.1 billion won), including a 36% year-over-year increase in U.S. sales to 3.58 billion won. CG MedTech is also diversifying its portfolio through initiatives like the acquisition of GDS, a digital dentistry company, to enter the dental market, and an exclusive supply agreement for NOVOSIS TRAUMA with Johnson & Johnson MedTech, a major player in the global medical device industry.
Under Yu’s leadership, CG MedTech is aiming to become a global leader in tissue regeneration medical devices, particularly in the orthopedic and spine markets. The company is also investing in infrastructure, such as a new headquarters, to support its growth ambitions. By combining CG MedTech’s manufacturing capabilities with CGBio’s R&D and marketing strengths, the two companies are working to create synergies that could make them competitive on a global scale, especially in the context of the growing orthopedic devices market, which is projected to reach $68.51 billion by 2030 with a CAGR of 14.5% from 2023, driven by the increasing prevalence of orthopedic disorders, particularly among aging populations.
WEBSITES
A relevant website for a company named CG MedTech Corporation, which also deals with orthopedic products like spinal systems and biologics, is www.cgmedt.com. This site includes sections on products like spinal implants (e.g., ANAX™ systems) and biologics, which matches the focus of the CG MedTech in your query. It also has a contact email (shimhun@cgmedt.com) and mentions a U.S. presence (CG MedTech MT USA), consistent with CGBio’s expansion strategy into North America.
However, there’s another website, www.cg-medtech.com, which claims to be for a CG MedTech focused on healthcare software solutions for hospitals, like electronic medical record systems. This does not align with the orthopedic implant focus of the company you described, so it’s likely a different entity with a similar name.
Additionally, since CG MedTech is a subsidiary of CGBio, you might also find relevant information on CGBio’s official website, www.cgbio.co.kr, which has an English version and includes news about CG MedTech, such as its establishment in the U.S.
Given the specifics of your query, the most relevant URL for the CG MedTech you’re referring to is likely www.cgmedt.com. If you need more details about their parent company, CGBio’s site at www.cgbio.co.kr could also be useful. Be cautious, as there are multiple companies with similar names, but the orthopedic focus and U.S. expansion point to these URLs.